Complement factor H related proteins (CFHRs) (Q26851489)

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

C3 glomerulonephritis/CFHR5 nephropathy is an endemic disease in Cyprus: clinical and molecular findings in 21 families.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Functions of C5a receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

A radiation hybrid map of complement factor H and factor H-related genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Complement dysregulation and disease: from genes and proteins to diagnostics and drugs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Structural findings in complement factor H-related proteins unravel the pathogenesis of C3 glomerulopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Alternative complement pathway assessment in patients with atypical HUS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Regulation of complement activation at the C3-level by serum resistant leptospires

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Immune evasion by acquisition of complement inhibitors: the mould Aspergillus binds both factor H and C4b binding protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Human complement factor H-related protein 4 binds and recruits native pentameric C-reactive protein to necrotic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Molecular basis of C-reactive protein binding and modulation of complement activation by factor H-related protein 4

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

A role for local inflammation in the formation of drusen in the aging eye.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Functional properties of complement factor H-related proteins FHR-3 and FHR-4: binding to the C3d region of C3b and differential regulation by heparin

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Complement factor H: sequence analysis of 221 kb of human genomic DNA containing the entire fH, fHR-1 and fHR-3 genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Structural and functional characterization of the product of disease-related factor H gene conversion

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Atypical hemolytic uremic syndrome and genetic aberrations in the complement factor H-related 5 gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Complement factor H binds malondialdehyde epitopes and protects from oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Seven new loci associated with age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Genome-wide association study identifies susceptibility loci for IgA nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

A rare penetrant mutation in CFH confers high risk of age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Complement: a key system for immune surveillance and homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Generation of C5a in the absence of C3: a new complement activation pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

T-cell regulation: with complements from innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Complement regulators and inhibitory proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

C3 glomerulopathy: a new classification

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

FHR-4A: a new factor H-related protein is encoded by the human FHR-4 gene.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Acute presentation and persistent glomerulonephritis following streptococcal infection in a patient with heterozygous complement factor H-related protein 5 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Complement. First of two parts

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Complement. Second of two parts

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Combined C3b and factor B autoantibodies and MPGN type II

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Thrombomodulin mutations in atypical hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Atypical hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Dimerization of complement factor H-related proteins modulates complement activation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Plasma lipopolysaccharide-binding protein is found associated with a particle containing apolipoprotein A-I, phospholipid, and factor H-related proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

The human factor H-related protein 4 (FHR-4). A novel short consensus repeat-containing protein is associated with human triglyceride-rich lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

The pH-regulated antigen 1 of Candida albicans binds the human complement inhibitor C4b-binding protein and mediates fungal complement evasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Binding of the Human Complement Regulators CFHR1 and Factor H by Streptococcal Collagen-like Protein 1 (Scl1) via Their Conserved C Termini Allows Control of the Complement Cascade at Multiple Levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Complement Resistance of Borrelia burgdorferi Correlates with the Expression of BbCRASP-1, a Novel Linear Plasmid-encoded Surface Protein That Interacts with Human Factor H and FHL-1 and Is Unrelated to Erp Proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Binding of human factor H-related protein 1 to serum-resistant Borrelia burgdorferi is mediated by borrelial complement regulator-acquiring surface proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD)

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Leptospiral Immunoglobulin-like Proteins Interact With Human Complement Regulators Factor H, FHL-1, FHR-1, and C4BP

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Rapid decrease in the prevalence of macrolide-resistant group A streptococci due to the appearance of two epidemic clones in Cantabria (Spain)

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

A novel deletion in the RCA gene cluster causes atypical hemolytic uremic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Renal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Factor H and CFHR1 polymorphisms associated with atypical Haemolytic Uraemic Syndrome (aHUS) are differently expressed in Tunisian and in Caucasian populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

The opportunistic human pathogenic fungus Aspergillus fumigatus evades the host complement system

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Loa loa Microfilariae evade complement attack in vivo by acquiring regulatory proteins from host plasma

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

M protein of the group A Streptococcus binds to the seventh short consensus repeat of human complement factor H

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

The yeast Candida albicans binds complement regulators factor H and FHL-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Borrelia burgdorferi erp (ospE-related) gene sequences remain stable during mammalian infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Recruitment of complement factor H-like protein 1 promotes intracellular invasion by group A streptococci

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

LfhA, a novel factor H-binding protein of Leptospira interrogans

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease)

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

The membrane attack complex of complement

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Relevance of complement factor H-related 1 (CFHR1) genotypes in age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Atypical haemolytic uraemic syndrome associated with a hybrid complement gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Abundant lipid and protein components of drusen

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Structural analysis of the C-terminal region (modules 18-20) of complement regulator factor H (FH)

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Determining the population frequency of the CFHR3/CFHR1 deletion at 1q32.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

A hybrid CFHR3-1 gene causes familial C3 glomerulopathy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Factor H and factor H-related protein 1 bind to human neutrophils via complement receptor 3, mediate attachment to Candida albicans, and enhance neutrophil antimicrobial activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Secreted pH-regulated antigen 1 of Candida albicans blocks activation and conversion of complement C3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Atypical hemolytic uremic syndrome-associated variants and autoantibodies impair binding of factor h and factor h-related protein 1 to pentraxin 3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Dihydrolipoamide dehydrogenase of Pseudomonas aeruginosa is a surface-exposed immune evasion protein that binds three members of the factor H family and plasminogen

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Overall neutralization of complement factor H by autoantibodies in the acute phase of the autoimmune form of atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Interaction between complement regulators and Streptococcus pyogenes: binding of C4b-binding protein and factor H/factor H-like protein 1 to M18 strains involves two different cell surface molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021

Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.MOLIMM.2013.06.001

7 January 2021